Think investing has to be boring or confusing? Think again! Join Jon Erlichman as he breaks down the latest market news, investment tips, and money moves — all served with a side of wit and zero financial mumbo jumbo. Whether you’re a newbie trying to figure out what a “ticker” even is, or a seasoned investor looking for a fresh take, Ticker Take makes finance fun, friendly, and maybe even a little entertaining. Tune in, learn something, and maybe laugh along the way. Your wallet will thank you.
All content for Ticker Take is the property of Jon Erlichman and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Think investing has to be boring or confusing? Think again! Join Jon Erlichman as he breaks down the latest market news, investment tips, and money moves — all served with a side of wit and zero financial mumbo jumbo. Whether you’re a newbie trying to figure out what a “ticker” even is, or a seasoned investor looking for a fresh take, Ticker Take makes finance fun, friendly, and maybe even a little entertaining. Tune in, learn something, and maybe laugh along the way. Your wallet will thank you.
Can you make money with biotech stocks? The sector is coming out of a brutal bear market, but it roared to life this week! Pfizer bought Metsera to catch up in the booming weight loss drug market, while UniQure shares surged after a promising Huntington’s disease trial update. Veteran biotech investor Eden Rahim calls it a “eureka moment." He joined us to share 10 stocks he’s extremely confident about — not the “go up or blow up” kind, but names with strong pipelines, mid-cap growth stories, and companies harnessing AI. Today's video is brought to you by MooMoo. As always this is not financial advice!
(Note: this video was filmed September 22nd, shortly before the UniQure news, which has since led to a surge in Clearpoint, which was one of Eden's picks. So kudos to Eden!)
Chapters:
0:00 Intro
0:21 Why did biotech stocks struggle so much?
1:15 Eden Rahim on the investing opportunity in biotech!
2:50 3 bio investing areas: mid-cap growth, emerging growth, and tech!
4:47 A word from today's sponsor, MooMoo! (link below!)
6:09 Stock pick 1 - Apellis Therapeutics (mid-cap growth stock)
8:33 Stock pick 2 - Legend Biotech (mid-cap growth stock)
11:35 Stock pick 3 - Ultragenyx Pharmaceutical (mid-cap growth stock)
13:24 Stock pick 4 - TG Therapeutics (mid-cap growth stock)
14:53 Stock pick 5 - Alpha Cognition (emerging growth stock)
17:41 Stock pick 6 - Cytokinetics (emerging growth stock)
19:43 Stock pick 7 - Crinetics Pharmaceuticals (emerging growth stock)
21:40 Stock pick 8 - Clearpoint Neuro (tech-related bio stock)
24:10 Stock pick 9 - Schrodinger (tech-related bio stock)
26:14 Stock pick 10 - Simulations Plus (tech-related bio stock)
Thanks to Eden for joining us! You can learn more about him here:
https://www.nextedgecapital.com/about-us/executive-team/staff-eden-rahim/
You can also follow him on X: @EdenRahim
Exec Producer/Co-Host: Caroline Lesley - https://www.instagram.com/caroline.lesley/
Check out the MooMoo link below for our limited time deal:
https://www.moomoo.com/ca/events/welcome_jon_erlichman
https://jonerlichman.substack.com/
● TikTok - https://www.tiktok.com/@jonerlichman?lang=en
● Instagram - https://www.instagram.com/jonerlichman/?hl=en
● X - https://x.com/JonErlichman
https://www.tickertakeonline.com/
Disclaimer: This content is for informational and educational purposes only. It is not intended to provide, and should not be relied upon as, legal, tax, accounting, investment, financial, or other professional advice. Viewers are encouraged to consult with qualified professionals regarding their individual circumstances.
No client, advisory, fiduciary, or professional relationship is created by viewing or interacting with this content. All information is provided “as is,” with no representations or warranties of any kind, express or implied. The creator makes no guarantees as to the accuracy, completeness, or timeliness of the information presented, and disclaims any liability for errors or omissions or for any losses, injuries, or damages arising from its use.
Any examples, case studies, or financial outcomes discussed are for illustrative purposes only and do not guarantee future results. Past performance is not indicative of future performance.
The views expressed are the personal opinions of the creator and do not necessarily reflect the views of any affiliated organizations or employers.
This video may contain copyrighted material, including images, music, or video clips, used under the fair use doctrine for purposes such as commentary, criticism, education, or research. All rights to third-party content remain with their respective owners.
This channel may include affiliate links. If you use these links to make a purchase, the channel may earn a small commission at no additional cost to you.
Ticker Take
Think investing has to be boring or confusing? Think again! Join Jon Erlichman as he breaks down the latest market news, investment tips, and money moves — all served with a side of wit and zero financial mumbo jumbo. Whether you’re a newbie trying to figure out what a “ticker” even is, or a seasoned investor looking for a fresh take, Ticker Take makes finance fun, friendly, and maybe even a little entertaining. Tune in, learn something, and maybe laugh along the way. Your wallet will thank you.
